Kbc Group Nv Astrazeneca PLC Transaction History

Kbc Group Nv

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $28,778 - $32,215	465 Added 40.43%	1,615 $108,000
Q2 2023 Feb 15, 2024	SELL	$69.91 - $75.81 $2.28 Million - $2.48 Million	-32,665 Reduced 95.29%	1,615 $115,000
Q1 2023 Feb 14, 2024	SELL	$63.15 - $71.6 $15,156 - $17,184	-240 Reduced 6.1%	3,692 $256,000
Q1 2023 May 04, 2023	SELL	$63.15 - $71.6 $972,131 - $1.1 Million	-15,394 Reduced 93.05%	1,150 $0
Q4 2022 Feb 14, 2024	SELL	$54.21 - $70.44 $890,616 - $1.16 Million	-16,429 Reduced 80.69%	3,932 $266,000
Q3 2022 Feb 15, 2024	BUY	$53.02 - $135.75 $1.73 Million - $4.43 Million	32,665 Added 2022.6%	34,280 $1.88 Million
Q3 2022 Nov 08, 2022	BUY	$53.02 - $135.75 $299,085 - $765,765	5,641 Added 51.74%	16,544 $907,000
Q2 2022 Feb 14, 2024	BUY	$59.26 - $71.14 $1.11 Million - $1.33 Million	18,746 Added 1160.74%	20,361 $1.35 Million
Q2 2022 Jul 26, 2022	BUY	$59.26 - $71.14 $646,111 - $775,639	10,903 New	10,903 $720,000
Q3 2021 Nov 10, 2021	SELL	$55.56 - $60.79 $122,732 - $134,285	-2,209 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$48.42 - $60.18 $10,119 - $12,577	209 Added 10.45%	2,209 $132,000
Q2 2018 Aug 03, 2018	BUY	$34.55 - $37.05 $69,100 - $74,100	2,000 New	2,000 $0

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.